Pursuant to Regulation 29 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Suven Life Sciences has informed that a Meeting of the Board of Directors of the Company will be held on Monday, the 31st January, 2022 at 11:30 am at the Registered Office of the Company at SDE Serene Chambers, 6th Floor, Road No 5, Banjara Hills, Hyderabad–500034, to consider, among other things, and take on record the following matter(s): To consider and approve the Un-audited Financial Results (Standalone and Consolidated) of the Company under Ind AS for the quarter ended 31st December, 2021 and related matters. The Trading Window for dealing in the securities of the company is already closed from 01st January, 2022 as per PIT Code of the Company and it will be opened from 03rd February, 2022.
The above information is a part of company’s filings submitted to BSE.
Company Name | CMP |
---|---|
Sun Pharma Inds. | 1486.55 |
Dr. Reddys Lab | 5860.25 |
Cipla | 1482.55 |
Zydus Lifesciences | 1072.35 |
Lupin | 1613.65 |
View more.. |